RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biocorp Production Stock

Biocorp Production ROCE 2025

Biocorp Production ROCE

-0.3

Ticker

ALCOR.PA

ISIN

FR0012788065

WKN

A14V4G

In 2025, Biocorp Production's return on capital employed (ROCE) was -0.3, a 0% increase from the 0 ROCE in the previous year.

Biocorp Production Aktienanalyse

What does Biocorp Production do?

Biocorp Production SA is a French company in the medical technology industry that manufactures innovative solutions for drug administration and injections. It was founded in 2004 under the name Biocorp sur mesure by Eric Dessertenne and later transformed into Biocorp Production SA. The business model of Biocorp Production SA is to produce innovative medical devices that can be used in medical applications. The company specializes in the development of smart devices that support injection administration. The devices produced by Biocorp can be operated by medical professionals or by patients themselves. One of the core areas of Biocorp Production SA is the development of smart medical technologies that aid in medication management. One such product is Vyoo, a device that assists patients in injecting medications. It is a digital device that facilitates injection administration and makes dosing safer. In addition to developing smart devices, Biocorp also offers other services, such as in the field of clinical trials for medical applications. The company works closely with pharmaceutical companies to develop medical devices and solutions for drug administration. Another important product is Mallya, an intelligent insulin administration system specifically designed for diabetes patients. It enables automated insulin administration tailored to the patient's needs, thereby improving their quality of life. Furthermore, Biocorp Production SA is also involved in the field of wearable medical technology. One example of a wearable device is Easylog, an electronic device for monitoring medical conditions. This device is particularly useful for patients with chronic diseases such as diabetes or asthma. Over the years, Biocorp Production SA has received numerous awards for its innovative products and services. For example, the company received the Innovation Award at the "Innovation Awards" in Paris in 2017 for the Mallya device. Overall, the company currently employs over 60 employees and has its headquarters in Issoire. It has branches in Germany and the USA. The products of Biocorp Production SA are sold in more than 80 countries worldwide. In summary, Biocorp Production SA is a leading provider of smart medical devices for drug administration and injections. The company strives to develop innovative solutions for the medical industry that are tailored to the needs of patients and medical professionals. With the products of Biocorp Production SA, medication administration becomes safer, easier, and more accurate. Biocorp Production ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Biocorp Production's Return on Capital Employed (ROCE)

Biocorp Production's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Biocorp Production's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Biocorp Production's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Biocorp Production’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Biocorp Production stock

What is the ROCE (Return on Capital Employed) of Biocorp Production this year?

The ROCE of Biocorp Production is -0.3 undefined this year.

How has the ROCE (Return on Capital Employed) of Biocorp Production developed compared to the previous year?

The ROCE of Biocorp Production has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Biocorp Production?

A high Return on Capital Employed (ROCE) indicates that Biocorp Production has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Biocorp Production?

A low ROCE (Return on Capital Employed) can indicate that Biocorp Production has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Biocorp Production impact the company?

An increase in the ROCE of Biocorp Production can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Biocorp Production affect the company?

A decrease in ROCE of Biocorp Production can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Biocorp Production?

Some factors that can affect Biocorp Production's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Biocorp Production so important for investors?

The ROCE of Biocorp Production is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Biocorp Production take to improve the ROCE?

To improve the ROCE, Biocorp Production can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Biocorp Production pay?

Over the past 12 months, Biocorp Production paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biocorp Production is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biocorp Production?

The current dividend yield of Biocorp Production is .

When does Biocorp Production pay dividends?

Biocorp Production pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biocorp Production?

Biocorp Production paid dividends every year for the past 0 years.

What is the dividend of Biocorp Production?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biocorp Production located?

Biocorp Production is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biocorp Production kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biocorp Production from 7/9/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/9/2025.

When did Biocorp Production pay the last dividend?

The last dividend was paid out on 7/9/2025.

What was the dividend of Biocorp Production in the year 2024?

In the year 2024, Biocorp Production distributed 0 EUR as dividends.

In which currency does Biocorp Production pay out the dividend?

The dividends of Biocorp Production are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biocorp Production

Our stock analysis for Biocorp Production Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biocorp Production Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.